252 related articles for article (PubMed ID: 12947204)
1. Preservation of myocardial microcirculation during mechanical reperfusion for myocardial ischemia with either abciximab or eptifibatide.
Stoupakis G; Orlando J; Kalia H; Skurnick J; Saric M; Arora R
J Invasive Cardiol; 2003 Sep; 15(9):476-80. PubMed ID: 12947204
[TBL] [Abstract][Full Text] [Related]
2. Use of abciximab prevents microcirculatory impairment in patients treated with coronary angioplasty for unstable angina: results of a prospective randomized study.
Prati F; Kwiatkowski P; Caroselli C; Imola F; Manzoli A; Fouad T; Corvo P; Ramazzotti V
Catheter Cardiovasc Interv; 2005 Oct; 66(2):165-9. PubMed ID: 16142802
[TBL] [Abstract][Full Text] [Related]
3. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory effects of abciximab and eptifibatide: a critical appraisal.
Kereiakes DJ
J Invasive Cardiol; 2003 Sep; 15(9):481-3. PubMed ID: 12947205
[No Abstract] [Full Text] [Related]
5. Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study.
Prati F; Petronio S; Van Boven AJ; Tendera M; De Luca L; de Belder MA; Galassi AR; Imola F; Montalescot G; Peruga JZ; Barnathan ES; Ellis S; Savonitto S;
JACC Cardiovasc Interv; 2010 Dec; 3(12):1284-91. PubMed ID: 21232723
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
[TBL] [Abstract][Full Text] [Related]
7. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
[TBL] [Abstract][Full Text] [Related]
8. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
[TBL] [Abstract][Full Text] [Related]
9. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time.
Aquilina M; Varani E; Balducelli M; Vecchi G; Frassineti V; Maresta A
J Invasive Cardiol; 2009 Mar; 21(3):115-20. PubMed ID: 19258642
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M
Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
[TBL] [Abstract][Full Text] [Related]
11. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
12. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
Bolognese L; Ducci K; Angioli P; Falsini G; Liistro F; Baldassarre S; Burali A
Circulation; 2004 Sep; 110(12):1592-7. PubMed ID: 15353489
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions.
Midei MG; Coombs VJ; Lowry DR; Drossner MN; Prewitt KC; Wang JC; Loughrey MB; Gottlieb SO
Cardiology; 2007; 107(3):172-7. PubMed ID: 16940721
[TBL] [Abstract][Full Text] [Related]
14. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.
Costantini CO; Stone GW; Mehran R; Aymong E; Grines CL; Cox DA; Stuckey T; Turco M; Gersh BJ; Tcheng JE; Garcia E; Griffin JJ; Guagliumi G; Leon MB; Lansky AJ
J Am Coll Cardiol; 2004 Jul; 44(2):305-12. PubMed ID: 15261923
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions.
Long KH; Ting HH; McMurtry EK; Lennon RJ; Wood DL; Holmes DR; Raveendran G; Rihal CS
Value Health; 2008; 11(3):462-9. PubMed ID: 18489669
[TBL] [Abstract][Full Text] [Related]
16. The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention.
Gurm HS; Smith DE; Collins JS; Share D; Riba A; Carter AJ; LaLonde T; Kline-Rogers E; O'Donnell M; Changezi H; Zughaib M; Safian R; Moscucci M;
J Am Coll Cardiol; 2008 Feb; 51(5):529-35. PubMed ID: 18237680
[TBL] [Abstract][Full Text] [Related]
17. [Use of Abciximab in threatening vascular occlusion after PTCA].
Mahrholdt H; Haase KK; Baumbach A; Dirr E; Oberhoff M; Schröder S; Athanasiadis A; Karsch KR
Z Kardiol; 2000 Aug; 89(8):722-9. PubMed ID: 11013978
[TBL] [Abstract][Full Text] [Related]
18. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
Gyöngyösi M; Domanovits H; Benzer W; Haugk M; Heinisch B; Sodeck G; Hödl R; Gaul G; Bonner G; Wojta J; Laggner A; Glogar D; Huber K;
Eur Heart J; 2004 Dec; 25(23):2125-33. PubMed ID: 15571828
[TBL] [Abstract][Full Text] [Related]
19. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty.
Petronio AS; Rovai D; Musumeci G; Baglini R; Nardi C; Limbruno U; Palagi C; Volterrani D; Mariani M
Eur Heart J; 2003 Jan; 24(1):67-76. PubMed ID: 12559938
[TBL] [Abstract][Full Text] [Related]
20. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
